The objective of this study was to determine the relationship between in vivo amino acid digestibility and protease inhibitors in commercial soybean meal (CSBM). A total of 12 CSBM samples were analyzed for: (1) trypsin inhibitor activity (TIA) utilizing the new official AOCS method (Ba 12a-2020). (2) chymotrypsin inhibitor activity (CIA) by the latest optimized method of Liu (2022. J. Food Sci. https://doi.org//10.1111/1750- 3841.16141), and (3) in vivo amino acid (AA) digestibility determined utilizing the precision-fed cecectomized rooster bioassay as described by Corray et al. (2018. Poult. Sci. 97:3987-3991). Linear and quadratic regressions of digestible AA coefficients on TIA and the summation of TIA and CIA (TIA+CIA) were conducted using PROC GLM in SAS (2013). The TIA ranged from 3.53 to 12.82 units inhibited (UI)/mg of CSBM. The TIA+CIA ranged from 8.74 to 23.40 UI/mg of CSBM. All 17 determined digestible AA coefficients for each of the 12 CSBM samples were negatively correlated with TIA and TIA+CIA values. For TIA, linear regression R-square values ranged from 0.48 (r= -0.69) for digestible lysine to 0.72 (r= -0.85) for digestible serine (P<0.05). There was no significant quadratic effect of TIA vs. digestible AA for all AA. For TIA+CIA, linear regression R-square values ranged from 0.41 (r= -0.64) for digestible cysteine to 0.77 (r= -0.88) for digestible serine (P<0.05); there was no significant quadratic effect of TIA+CIA vs. digestible AA for all AA.